Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling

Yixuan Qiu, Jiaming Yu, Yi Li, +7

Annals of Medicine

New‐onset diabetes after liver transplantation and its impact on complications and patient survival

Chaoyang Lv, Yao Zhang, Xianying Chen, +11

Journal of Diabetes

Influencing Factors of New-Onset Diabetes after a Renal Transplant and Their Effects on Complications and Survival Rate

Chaoyang Lv, Minling Chen, Ming Xu, +8

PLoS ONE

Ileal FXR-FGF15/19 signaling activation improves skeletal muscle loss in aged mice

Yixuan Qiu, Jiaming Yu, Xueying Ji, +5

Mechanisms of Ageing and Development

InflammationMuscle FunctionMolecular PhysiologyIleal Fxr-fgf15/19Skeletal Muscle +8

Lipid accumulation-induced hepatocyte senescence regulates the activation of hepatic stellate cells through the Nrf2-antioxidant response element pathway

Huiyuan Yu, Xin Jiang, Fangyuan Dong, +7

Experimental Cell Research

InflammationHepatologyAgingHepatic Stellate CellsLongevity +12

Donor liver steatosis: A risk factor for early new‐onset diabetes after liver transplantation

Mengjuan Xue, Chaoyang Lv, Xianying Chen, +11

Journal of Diabetes Investigation

Secretory Galectin-3 promotes hepatic steatosis via regulation of the PPARγ/CD36 signaling pathway

Huiyuan Yu, Fan Yang, Wentao Zhong, +9

Cellular Signalling

InflammationSignal TransductionHepatologySignaling PathwayLiver Physiology +10

Curcumol suppresses RANKL-induced osteoclast formation by attenuating the JNK signaling pathway

Mingxiang Yu, Xianying Chen, Chaoyang Lv, +6

Biochemical and Biophysical Research Communications

Orthopaedic SurgeryBone Morphogenic ProteinRankl-induced Osteoclast FormationOsteoarthritisCellular Physiology +6

Butyrate promotes C2C12 myoblast proliferation by activating ERK/MAPK pathway

Li Guan, Ziyi Cao, Ziyue Pan, +4

Molecular Omics

Identifying SLC27A5 as a potential prognostic marker of hepatocellular carcinoma by weighted gene co-expression network analysis and in vitro assays

Fan Zhang, Mengjuan Xue, Xin Jiang, +5

Cancer Cell International